Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]

Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]

Bibliographic Details
Main Authors: Takahito Hara, Akiko Kimura, Tohru Miyazaki, Hiroshi Tanaka, Megumi Morimoto, Katsuhiko Nakai, Junpei Soeda
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Biochemistry and Biophysics Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580820301060
id doaj-2a65e57fdf3a42a3a16790812ebf494e
record_format Article
spelling doaj-2a65e57fdf3a42a3a16790812ebf494e2020-12-21T04:46:12ZengElsevierBiochemistry and Biophysics Reports2405-58082020-12-0124100797Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]Takahito Hara0Akiko Kimura1Tohru Miyazaki2Hiroshi Tanaka3Megumi Morimoto4Katsuhiko Nakai5Junpei Soeda6Innovation Promotion, Shonan Research Central Office, Research, Takeda Pharmaceutical Company Limited, 2-26-1 Muraoka-Higashi, Fujisawa-shi, Kanagawa, 251-8555, Japan; Corresponding author.Oncology Therapeutic Area Unit for Japan & Asia, Takeda Pharmaceutical Company Limited, 4-1-1 Dosho-machi Chuo-ku Osaka-shi, Osaka, 540-8645, JapanDepartment of Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8668, JapanAxcelead Drug Discovery Partners, Inc., 2-26-1Muraoka-Higashi, Fujisawa-shi, Kanagawa, 251-0012, JapanInnovation Promotion, Shonan Research Central Office, Research, Takeda Pharmaceutical Company Limited, 2-26-1 Muraoka-Higashi, Fujisawa-shi, Kanagawa, 251-8555, JapanOncology Therapeutic Area Unit for Japan & Asia, Takeda Pharmaceutical Company Limited, 4-1-1 Dosho-machi Chuo-ku Osaka-shi, Osaka, 540-8645, JapanDepartment of Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8668, Japan; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2405580820301060
collection DOAJ
language English
format Article
sources DOAJ
author Takahito Hara
Akiko Kimura
Tohru Miyazaki
Hiroshi Tanaka
Megumi Morimoto
Katsuhiko Nakai
Junpei Soeda
spellingShingle Takahito Hara
Akiko Kimura
Tohru Miyazaki
Hiroshi Tanaka
Megumi Morimoto
Katsuhiko Nakai
Junpei Soeda
Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
Biochemistry and Biophysics Reports
author_facet Takahito Hara
Akiko Kimura
Tohru Miyazaki
Hiroshi Tanaka
Megumi Morimoto
Katsuhiko Nakai
Junpei Soeda
author_sort Takahito Hara
title Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
title_short Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
title_full Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
title_fullStr Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
title_full_unstemmed Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
title_sort corrigendum to “cabozantinib inhibits axl- and met-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [biochem. biophys. rep. 21 (2020) 100726]
publisher Elsevier
series Biochemistry and Biophysics Reports
issn 2405-5808
publishDate 2020-12-01
url http://www.sciencedirect.com/science/article/pii/S2405580820301060
work_keys_str_mv AT takahitohara corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
AT akikokimura corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
AT tohrumiyazaki corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
AT hiroshitanaka corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
AT megumimorimoto corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
AT katsuhikonakai corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
AT junpeisoeda corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726
_version_ 1724375670611509248

Similar Items